Patents by Inventor José Ignacio Miranda Murua

José Ignacio Miranda Murua has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11377427
    Abstract: The present invention relates to 1,2,3-triazoles of formula: useful for improving or restoring the intracellular calcium homeostasis and RyR-calstabin binding function in human and animal cells. The present invention also relates to methods for synthesizing said compounds, to pharmaceutical compositions containing them, and to the use thereof for preventing or treating skeletal muscle, heart and nervous system disorders.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: July 5, 2022
    Assignees: UNIVERSIDAD DEL PAIS VASCO, ADMINISTRACION GENERAL DE LA COMUNIDAD AUTONOMA DE EUSKADI
    Inventors: Ainara Vallejo Illarramendi, Adolfo Jose Lopez De Munain Arregi, Pablo Ferron Celma, Jesus Maria Aizpurua Iparraguirre, Aitziber Irastorza Epelde, Jose Ignacio Miranda Murua, Ivan Toral Ojeda, Garazi Aldanondo Aristizabal
  • Publication number: 20200317625
    Abstract: The present invention relates to 1,2,3-triazoles of formula: useful for improving or restoring the intracellular calcium homeostasis and RyR-calstabin binding function in human and animal cells. The present invention also relates to methods for synthesizing said compounds, to pharmaceutical compositions containing them, and to the use thereof for preventing or treating skeletal muscle, heart and nervous system disorders.
    Type: Application
    Filed: May 23, 2017
    Publication date: October 8, 2020
    Inventors: Ainara VALLEJO ILLARRAMENDI, Adolfo Jose LOPEZ DE MUNAIN ARREGI, Pablo FERRON CELMA, Jesus Maria AIZPURUA IPARRAGUIRRE, Aitziber IRASTORZA EPELDE, Jose Ignacio MIRANDA MURUA, Ivan TORAL OJEDA, Garazi ALDANONDO ARISTIZABAL
  • Publication number: 20130172273
    Abstract: Cyclotetrapeptides of formula (I) or their pharmaceutically acceptable salts, cyclo[Arg-Asp-(beta-Lactam)] (I) wherein (beta-Lactam) is a biradical of the formula (II) wherein the terminal NH group of the (beta-Lactam) is attached to the ?-carbonyl group of the aspartic residue (Asp), and the terminal carbonyl group of the (beta-Lactam) is attached to the ?-amino group the arginine residue (Arg); processes for their preparation, and pharmaceutical compositions containing them, as well as their use in human and animal therapy.
    Type: Application
    Filed: July 14, 2011
    Publication date: July 4, 2013
    Applicant: GENETADI BIOTECH, S.L.
    Inventors: Jesús María Aizpurua Iparraguirre, Joseba Oyarbide Vicuña, Xabier Fernández Oyón, José Ignacio Miranda Murua, José Ignacio Gamboa Landa, Silvia Ávila Flores, José Luis Castrillo Diez